<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJRD</journal-id><journal-title-group><journal-title>Open Journal of Respiratory Diseases</journal-title></journal-title-group><issn pub-type="epub">2163-940X</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojrd.2022.122003</article-id><article-id pub-id-type="publisher-id">OJRD-116552</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Destroyed Lung Syndrome: A Review of 31 Published Cases
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>John</surname><given-names>Osarenkhoe</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Henry</surname><given-names>Aiwuyo</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ogbomo</surname><given-names>Aisosa</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Umuerri</surname><given-names>Ejiroghene</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Cardiology Unit, Department of Medicine, University of Benin Teaching Hospital, Benin, Nigeria</addr-line></aff><aff id="aff1"><addr-line>Department of Medicine, Igbinedion University Teaching Hospital, Okada, Nigeria</addr-line></aff><aff id="aff2"><addr-line>Department of Medicine, Chevron Hospital, Warri, Nigeria</addr-line></aff><aff id="aff4"><addr-line>Department of Medicine, Delta State University, Delta, Nigeria</addr-line></aff><pub-date pub-type="epub"><day>15</day><month>04</month><year>2022</year></pub-date><volume>12</volume><issue>02</issue><fpage>37</fpage><lpage>43</lpage><history><date date-type="received"><day>18,</day>	<month>January</month>	<year>2022</year></date><date date-type="rev-recd"><day>12,</day>	<month>April</month>	<year>2022</year>	</date><date date-type="accepted"><day>15,</day>	<month>April</month>	<year>2022</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  <b>Background:</b>
   Destroyed lung is a lung condition commonly caused by tuberculosis. Other causes include
   
  bronchiectasis, aspergilloma, emphysema
  , etc. It is characterized by extensive lung destruction and reduced lung function. Chest X-ray, chest CT, bronchography, and ventilation-perfusion ratio scan are the commonest radiologic diagnostic tools. Treatment of choice may include pneumonectomy. The study aims to highlight the common causes of destroyed lung and the major presenting complaints based on age, sex and affected lungs. <b>Method:</b> Published cases from English medical journals were evaluated and analyzed. <b>Results:</b> 31 published cases on destroyed lung were reviewed. 58.1% showed that the left lung was the most commonly affected lung. The condition was more common in males (71%). Based on our review, the commonest causes are pneumonia and tuberculosis at 25.9% and 22.8%, respectively. <b>Conclusion:</b> Pneumonia and Tuberculosis seem to be the commonest causes of destroyed lung based on our review, with left sided affectation being more predominant.
 
</p></abstract><kwd-group><kwd>Destroyed Lung</kwd><kwd> Tuberculosis</kwd><kwd> Bronchiectasis</kwd><kwd> Aspergilloma</kwd><kwd> Emphysema</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Destroyed lung is a term used to describe extensive destruction of the lungs [<xref ref-type="bibr" rid="scirp.116552-ref1">1</xref>]. Usually noted in radiological studies and characterized by markedly reduced ventilation to perfusion ratio [<xref ref-type="bibr" rid="scirp.116552-ref2">2</xref>]. Destroyed lung is often caused by inflammatory diseases; the commonest being tuberculosis [<xref ref-type="bibr" rid="scirp.116552-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.116552-ref3">3</xref>]. Other causes include bronchiectasis, emphysema, aspergilloma, and pneumonia [<xref ref-type="bibr" rid="scirp.116552-ref2">2</xref>]. Complications of destroyed lungs often include irreversible respiratory insufficiency, massive hemoptysis, empyema, secondary fungal infections, septicaemia and left-right shunt [<xref ref-type="bibr" rid="scirp.116552-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.116552-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.116552-ref4">4</xref>]. The contralateral lungs may show hyperinflation [<xref ref-type="bibr" rid="scirp.116552-ref4">4</xref>]. Chest X-ray, chest CT, bronchography, and ventilation-perfusion ratio scan are the commonest radiologic diagnostic tools [<xref ref-type="bibr" rid="scirp.116552-ref5">5</xref>]. Chest X-ray findings in affected lungs show, diffuse opacity with multiple cavities or a large single cavity [<xref ref-type="bibr" rid="scirp.116552-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.116552-ref6">6</xref>]. Although, a high-risk procedure, pneumonectomy may be indicated in the management of destroyed lungs to either resolve or prevent complications [<xref ref-type="bibr" rid="scirp.116552-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.116552-ref3">3</xref>].</p></sec><sec id="s2"><title>2. Methods and Materials</title><p>We reviewed 31 published case reports of destroyed lung retrieved from PubMed and Google Scholar databases. For the purpose of our study, we examined cases whom a diagnosis of destructive lung was made by authors using radiologic criteria.</p><p>The major presenting complaint for destroyed lung was noted, however, we focused on respiratory failure and hemoptysis in our analysis because of its potential prognostic implications. Distribution of destroyed lung cases were noted across, sex and age groups.</p><p>Destroyed lung was classified according to which lung (s) was/were affected. For the purpose of the study: right lung, left lung or bilateral. The underlying conditions implicated in destroyed lung and how its association with the lung affected was also noted.</p><p>Statistical analysis was done using IBM SPSS version 26 and Chi-square test of independence as well as Goodness of Fit test was used to evaluate the level of significance (P-value). Significant result was set at P-value &lt; 0.05.</p></sec><sec id="s3"><title>3. Results</title><p><xref ref-type="table" rid="table1">Table 1</xref> shows that the most commonly affected side in destroyed lung is the left (n = 18, 58.1%), followed by the right (n = 11, 35.5%). 2 (6.5%) of cases had bilateral lung affectation.</p><p><xref ref-type="table" rid="table2">Table 2</xref> showed that more men (n = 22, 71.0%) than women (n = 9, 29.0%) had destroyed lungs. Even though statistical test showed no age predilection for destroyed lung (P = 0.07), it was more common among those less than 40 years (n = 16, 51.6%). Mean age = 38.29 &#177; 23.43.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Distribution of affected lungs in destroyed lungs</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"  ></th><th align="center" valign="middle" >n (%)</th><th align="center" valign="middle" >P-value</th></tr></thead><tr><td align="center" valign="middle"  rowspan="3"  >Affected lungs N = 31</td><td align="center" valign="middle" >Right</td><td align="center" valign="middle" >11 (35.5)</td><td align="center" valign="middle" >0.002</td></tr><tr><td align="center" valign="middle" >Left</td><td align="center" valign="middle" >18 (58.1)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Bilateral</td><td align="center" valign="middle" >2 (6.5)</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>P-value in <xref ref-type="table" rid="table1">Table 1</xref> compares any significance difference between the prevalence of destroyed lung in the right lung, left lung or both (bilateral).</p><p><xref ref-type="table" rid="table3">Table 3</xref> shows the causes of destroyed lung with tuberculosis and pneumonia being the commonest at 25.8% and 22.9%, respectively. P = 0.05.</p><p><xref ref-type="table" rid="table4">Table 4</xref> showed that there was no significant association between affected lungs and the cause. However, bilateral affectation only occurred in cases caused by pneumonia (n = 2, 100%).</p><p><xref ref-type="table" rid="table5">Table 5</xref> shows that 82.8% of cases presented with respiratory failure while 24.1% of cases had a history of hemoptysis.</p><p><xref ref-type="table" rid="table6">Table 6</xref> shows that most of the cases presented with complaints of respiratory failure across sex, age category and affected lungs.</p></sec><sec id="s4"><title>4. Discussion</title><p>Destroyed lung is a condition that describes a non-functional lung usually associated with recurrent or chronic lung infections [<xref ref-type="bibr" rid="scirp.116552-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.116552-ref4">4</xref>]. The commonest affected</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Distribution of destroyed lungs by sex and age category</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"  ></th><th align="center" valign="middle" >n (%) N = 31</th><th align="center" valign="middle" >P-value</th></tr></thead><tr><td align="center" valign="middle"  rowspan="2"  >Sex of patient</td><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >9 (29.0)</td><td align="center" valign="middle" >0.02</td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >22 (71.0)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Age category</td><td align="center" valign="middle" >&lt;40 years</td><td align="center" valign="middle" >16 (51.6)</td><td align="center" valign="middle" >0.07</td></tr><tr><td align="center" valign="middle" >40 - 65 years</td><td align="center" valign="middle" >9 (29.0)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&gt;60 years</td><td align="center" valign="middle" >6 (19.4)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Mean Age &#177; SD = 38.29 &#177; 23.43</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>P-value in <xref ref-type="table" rid="table2">Table 2</xref> compares any significance difference between the prevalence of destroyed lung between males and females, as well as the different age groups.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Causes of destroyed lungs</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"  ></th><th align="center" valign="middle" >n (%) N = 31</th><th align="center" valign="middle" >P-value</th></tr></thead><tr><td align="center" valign="middle"  rowspan="11"  >Underlying condition</td><td align="center" valign="middle" >Pneumonia</td><td align="center" valign="middle" >8 (25.8)</td><td align="center" valign="middle" >0.05</td></tr><tr><td align="center" valign="middle" >Tuberculosis</td><td align="center" valign="middle" >7 (22.9)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Aspergillosis</td><td align="center" valign="middle" >4 (12.9)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Sepsis</td><td align="center" valign="middle" >2 (6.5)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Silicosis</td><td align="center" valign="middle" >1 (3.2)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >BOS</td><td align="center" valign="middle" >1 (3.2)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Foreign body</td><td align="center" valign="middle" >1 (3.2)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Lung Ca</td><td align="center" valign="middle" >3 (9.7)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Emphysema</td><td align="center" valign="middle" >2 (6.5)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Tracheo/bronchooesophageal fistula</td><td align="center" valign="middle" >1 (3.2)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Mucormycosis</td><td align="center" valign="middle" >1 (3.2)</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>P-value in <xref ref-type="table" rid="table3">Table 3</xref> compares any statistically significant difference in at least two causes of destroyed lung.</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Association between affected lungs and causes lungs</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"   rowspan="3"  ></th><th align="center" valign="middle"  colspan="6"  >Affected lungs</th></tr></thead><tr><td align="center" valign="middle"  colspan="2"  >Right</td><td align="center" valign="middle"  colspan="2"  >Left</td><td align="center" valign="middle"  colspan="2"  >Bilateral</td></tr><tr><td align="center" valign="middle" >freq</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >freq</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >freq</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle"  rowspan="11"  >Underlying condition</td><td align="center" valign="middle" >Pneumonia</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >18.18%</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >22.22%</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >100.00%</td></tr><tr><td align="center" valign="middle" >Tuberculosis</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >27.27%</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >22.22%</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00%</td></tr><tr><td align="center" valign="middle" >Aspergillosis</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >9.09%</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >16.67%</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00%</td></tr><tr><td align="center" valign="middle" >Sepsis</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >9.09%</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >5.56%</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00%</td></tr><tr><td align="center" valign="middle" >Silicosis</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00%</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >5.56%</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00%</td></tr><tr><td align="center" valign="middle" >BOS</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00%</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >5.56%</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00%</td></tr><tr><td align="center" valign="middle" >Foreign body</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00%</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >5.56%</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00%</td></tr><tr><td align="center" valign="middle" >Lung Ca</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >18.18%</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >5.56%</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00%</td></tr><tr><td align="center" valign="middle" >Emphysema</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00%</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >11.11%</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00%</td></tr><tr><td align="center" valign="middle" >Tracheo/bronchooesophageal fistula</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >9.09%</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00%</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00%</td></tr><tr><td align="center" valign="middle" >Mucormycosis</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >9.09%</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00%</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00%</td></tr></tbody></table></table-wrap><p>(X<sup>2</sup> = 14.592; df = 20; P = 0.799).</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Distribution of complaints at time of presentation</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"   rowspan="2"  ></th><th align="center" valign="middle"  colspan="2"  >Presenting complaints</th></tr></thead><tr><td align="center" valign="middle" >Hemoptysis n (%)</td><td align="center" valign="middle" >Resp failure n (%)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Sex of patient</td><td align="center" valign="middle" >Female (N = 9)</td><td align="center" valign="middle" >2 (22.2)</td><td align="center" valign="middle" >8 (88.9)</td></tr><tr><td align="center" valign="middle" >Male (N = 22)</td><td align="center" valign="middle" >5 (22.7)</td><td align="center" valign="middle" >16 (72.7)</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Age Category</td><td align="center" valign="middle" >&lt;40 (N = 16)</td><td align="center" valign="middle" >5 (31.3)</td><td align="center" valign="middle" >12 (75.0)</td></tr><tr><td align="center" valign="middle" >40 - 65 (N = 9)</td><td align="center" valign="middle" >2 (22.2)</td><td align="center" valign="middle" >7 (77.8)</td></tr><tr><td align="center" valign="middle" >&gt;65 (N = 6)</td><td align="center" valign="middle" >0 (0.0)</td><td align="center" valign="middle" >5 (83.3)</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Affected lungs</td><td align="center" valign="middle" >Right (N = 11)</td><td align="center" valign="middle" >2 (18.2)</td><td align="center" valign="middle" >8 (34.8)</td></tr><tr><td align="center" valign="middle" >Left (N = 18)</td><td align="center" valign="middle" >5 (27.8)</td><td align="center" valign="middle" >14 (77.8)</td></tr><tr><td align="center" valign="middle" >Bilateral (N = 2)</td><td align="center" valign="middle" >0 (0.0)</td><td align="center" valign="middle" >2 (100.0)</td></tr></tbody></table></table-wrap><table-wrap id="table6" ><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> Distribution of presenting complaints across sex, age category and affected lungs</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"   rowspan="2"  ></th><th align="center" valign="middle"  colspan="2"  >Responses</th><th align="center" valign="middle"  rowspan="2"  >Percent of Cases</th></tr></thead><tr><td align="center" valign="middle" >N</td><td align="center" valign="middle" >Percent</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Presenting complaints<sup>a</sup></td><td align="center" valign="middle" >Respiratory failure</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >77.4%</td><td align="center" valign="middle" >82.8%</td></tr><tr><td align="center" valign="middle" >Hemoptysis</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >22.6%</td><td align="center" valign="middle" >24.1%</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Total</td><td align="center" valign="middle" >31</td><td align="center" valign="middle" >100.0%</td><td align="center" valign="middle" >106.9%</td></tr></tbody></table></table-wrap><p>side as stated by a number of literatures is the left lung [<xref ref-type="bibr" rid="scirp.116552-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.116552-ref7">7</xref>]. Our review showed a higher percentage (58.1%) affected the left lung than the right lung (35.5%). Whereas, 6.5% involved both lungs. More significant differences are noted in other studies: Mısırlıoğlu AK et al. showed 74.4% affectation and Rajasekaran S showed 81.8% left lung affectation [<xref ref-type="bibr" rid="scirp.116552-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.116552-ref7">7</xref>].</p><p>Our review showed significant difference between male (71%) and female (29%) distribution of destroyed lung; P = 0.002, which corresponded to another study with significant sex predilection with male to female ratio at 70.5% to 29.5% [<xref ref-type="bibr" rid="scirp.116552-ref7">7</xref>]. Other studies showed no sex predilection in destroyed lung [<xref ref-type="bibr" rid="scirp.116552-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.116552-ref3">3</xref>].</p><p>Variability was noted in the mean age of cases with destroyed lung across different studies. The mean (&#177;SD) ranged from 31.7 (&#177;10.8) to 65.6 (&#177;0.5) [<xref ref-type="bibr" rid="scirp.116552-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.116552-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.116552-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.116552-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.116552-ref11">11</xref>]. Our review showed a mean age of 38.29 &#177; 23.43. The variability in mean age seen across different studies could be as a result of the underlying cause of destroyed lung.</p><p>Some studies mention tuberculosis as the commonest cause of destroyed lung [<xref ref-type="bibr" rid="scirp.116552-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.116552-ref3">3</xref>]. However, bronchiectasis has been implicated in some research as the most common underlying condition leading to destroyed lung. Sayir F. et al. implicated bronchiectasis in 62.5% of cases and tuberculosis in 28.1% of cases [<xref ref-type="bibr" rid="scirp.116552-ref8">8</xref>]. Mısırlıoğlu AK et al. implicated bronchiectasis and tuberculosis in 51% and 34% of cases, respectively [<xref ref-type="bibr" rid="scirp.116552-ref2">2</xref>]. Halezeroglu S. et al. and Eren Ş. et al., also had bronchiectasis as the most common underlying disease in destroyed lung [<xref ref-type="bibr" rid="scirp.116552-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.116552-ref12">12</xref>]. Other commonly implicated underlying conditions include, pulmonary hypoplasia, necrotizing lung disease, aspergillosis, and foreign body aspiration [<xref ref-type="bibr" rid="scirp.116552-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.116552-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.116552-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.116552-ref8">8</xref>]. From our review, the commonest underlying condition was pneumonia (25.8%) and tuberculosis (22.9%). Aspergillosis and lung cancer were also implicated in 12.9% and 6.5% of cases, respectively. 1 case of foreign body aspiration was noted.</p><p>Hemoptysis and respiratory failure has been a recurring entity in destroyed lung, across studies [<xref ref-type="bibr" rid="scirp.116552-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.116552-ref11">11</xref>]. Moreso, respiratory failure, as it can be used to predict prognosis [<xref ref-type="bibr" rid="scirp.116552-ref10">10</xref>].</p></sec><sec id="s5"><title>5. Conclusion</title><p>Overall, destroyed lung is generally caused by chronic lung infection, the commonest cause being tuberculosis and pneumonia. Affectation of the left lung is more common compared to the right, and occurs more in males, according to our study. Respiratory failure seems to be a more common presentation compared to hemoptysis. Although clinically, age predilection is noted in the disease, there is no statistically significant age predilection noted in the disease as well as the presenting complaints.</p></sec><sec id="s6"><title>Recommendations</title><p>There is need to do similar studies using larger sample size.</p></sec><sec id="s7"><title>Limitations of This Study</title><p>The sample size was highly limited because there are not a lot of individual published cases of destroyed lung on journals.</p></sec><sec id="s8"><title>Acknowledgements</title><p>I hereby acknowledge Dr. Bassey, Aniekeme for his role in picking the appropriate statistical tool to analyse the collected data. He also played a role in proofreading and organising the content of this article.</p></sec><sec id="s9"><title>Competing Interests</title><p>There is no competing interest.</p></sec><sec id="s10"><title>Cite this paper</title><p>Osarenkhoe, J., Aiwuyo, H., Aisosa, O. and Ejiroghene, U. (2022) Destroyed Lung Syndrome: A Review of 31 Published Cases. Open Journal of Respiratory Diseases, 12, 37-43. https://doi.org/10.4236/ojrd.2022.122003</p></sec></body><back><ref-list><title>References</title><ref id="scirp.116552-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Carette, M.F., Blanchon, F., Milleron, B. and Brocard, H. (1979) Destroyed Lung (Author’s Transl). La semaine des hopitaux: Organe fonde par l’Association d’enseignement medical des hopitaux de Paris, 55, 843-853. https://europepmc.org/article/med/225799</mixed-citation></ref><ref id="scirp.116552-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">M&amp;#305;s&amp;#305;rl&amp;#305;o&amp;#287;lu, A.K., Bayram, S., K&amp;#305;ral, H., A&amp;#287;ca, M.&amp;#199;., Aky&amp;#305;l, F.T., Alpay, L., Baysungur, V. and Yal&amp;#231;&amp;#305;nkaya, I. (2018) Factors Affecting Complication Rates of Pneumonectomy in Destroyed Lung. Turkish Journal of Thoracic and Cardiovascular Surgery, 26, 272. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024126/https://doi.org/10.5606/tgkdc.dergisi.2018.14635</mixed-citation></ref><ref id="scirp.116552-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Kosar, A., Orki, A., Kiral, H., Demirhan, R. and Arman, B. (2010) Pneumonectomy in Children for Destroyed Lung: Evaluation of 18 Cases. The Annals of Thoracic Surgery, 89, 226-231. https://www.academia.edu/download/42178993/Pneumonectomy_in_children_for_destroyed_20160205-8971-or3e7h.pdfhttps://doi.org/10.1016/j.athoracsur.2009.10.007</mixed-citation></ref><ref id="scirp.116552-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Crespo, M.G., Martinez, F.A. and Gonzalez, F.C. (2016) Destroyed Lung Complicated with Empyema. Imaging in Medicine, 4. https://www.openaccessjournals.com/articles/destroyed-lung-complicated-with-empyema.html</mixed-citation></ref><ref id="scirp.116552-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Eren, &amp;#350;., Eren, M.N. and Balc&amp;#305;, A.E. (2003) Pneumonectomy in Children for Destroyed Lung and the Long-Term Consequences. The Journal of Thoracic and Cardiovascular Surgery, 126, 574-581. https://www.sciencedirect.com/science/article/pii/S0022522303005865https://doi.org/10.1016/S0022-5223(03)00586-5</mixed-citation></ref><ref id="scirp.116552-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Porres, D.V., Persiva, O., Pallisa, E. and Andreu, J. (2017) Radiological Findings of Unilateral Tuberculous Lung Destruction. Insights into Imaging, 8, 271-277. https://link.springer.com/content/pdf/10.1007/s13244-017-0547-4.pdfhttps://doi.org/10.1007/s13244-017-0547-4</mixed-citation></ref><ref id="scirp.116552-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Rajasekaran, S., Vallinayagi, V. and Jeyaganesh, D. (1999) Unilateral Lung Destruction: A Computed Tomographic Evaluation. Indian Journal of Tuberculosis, 46, 183-188. https://www.researchgate.net/profile/Sikhamani-Rajasekaran/publication/259368474_Unilateral_lung_destruction_a_computed_tomographic_evaluation/links/0046352b3de0092e5c000000/Unilateral-lung-destruction-a-computed-tomographic-evaluation.pdf</mixed-citation></ref><ref id="scirp.116552-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Sayir, F., Ocakcioglu, I., #350;ehito&amp;#287;ullar&amp;#305;, A. and &amp;#199;obano&amp;#287;lu, U. (2019) Clinical Analysis of Pneumonectomy for Destroyed Lung: A Retrospective Study of 32 Patients. General Thoracic and Cardiovascular Surgery, 67, 530-536. https://link.springer.com/article/10.1007/s11748-018-01055-6https://doi.org/10.1007/s11748-018-01055-6</mixed-citation></ref><ref id="scirp.116552-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Rhee, C.K., Yoo, K.H., Lee, J.H., Park, M.J., Kim, W.J., Park, Y.B., Hwang, Y.I., Kim, Y.S., Jung, J.Y., Moon, J.Y. and Rhee, Y.K. (2013) Clinical Characteristics of Patients with Tuberculosis-Destroyed Lung. The International Journal of Tuberculosis and Lung Disease, 17, 67-75. https://www.ingentaconnect.com/content/iuatld/ijtld/2013/00000017/00000001/art00013https://doi.org/10.5588/ijtld.12.0351</mixed-citation></ref><ref id="scirp.116552-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Ryu, Y.J., Lee, J.H., Chun, E.M., Chang, J.H. and Shim, S.S. (2011) Clinical Outcomes and Prognostic Factors in Patients with Tuberculous Destroyed Lung. The International Journal of Tuberculosis and Lung Disease, 15, 246-250. https://www.ingentaconnect.com/content/iuatld/ijtld/2011/00000015/00000002/art00019</mixed-citation></ref><ref id="scirp.116552-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Lee, J.H. and Chang, J.H. (2003) Lung Function in Patients with Chronic Airflow Obstruction Due to Tuberculous Destroyed Lung. Respiratory Medicine, 97, 1237-1242. https://www.sciencedirect.com/science/article/pii/S0954611103002555https://doi.org/10.1016/S0954-6111(03)00255-5</mixed-citation></ref><ref id="scirp.116552-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Halezeroglu, S., Keles, M., Uysal, A., Celik, M., Senol, C., Haciibrahimoglu, G. and Arman, B. (1997) Factors Affecting Postoperative Morbidity and Mortality in Destroyed Lung. The Annals of Thoracic Surgery, 64, 1635-1638. https://www.sciencedirect.com/science/article/abs/pii/S0003497597009995https://doi.org/10.1016/S0003-4975(97)00999-5</mixed-citation></ref></ref-list></back></article>